414 related articles for article (PubMed ID: 24409065)
1. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Hu YH; Liu M; Yi W; Cao YJ; Cai HD
World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
4. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT
J Hepatol; 2014 Sep; 61(3):502-7. PubMed ID: 24801414
[TBL] [Abstract][Full Text] [Related]
7. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
9. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.
Pan CQ; Mi LJ; Bunchorntavakul C; Karsdon J; Huang WM; Singhvi G; Ghany MG; Reddy KR
Dig Dis Sci; 2012 Sep; 57(9):2423-9. PubMed ID: 22543886
[TBL] [Abstract][Full Text] [Related]
12. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
[TBL] [Abstract][Full Text] [Related]
14. Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.
Tsai PJ; Chang A; Yamada S; Tsai N; Bartholomew ML
Dig Dis Sci; 2014 Nov; 59(11):2797-803. PubMed ID: 24898100
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
Virine B; Osiowy C; Gao S; Wang T; Castillo E; Martin SR; Lee SS; Simmonds K; van Marle G; Coffin CS
PLoS One; 2015; 10(10):e0140070. PubMed ID: 26474400
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
Ding Y; Cao L; Zhu L; Huang Y; Lin C; Wang Y; Liu Y; Sheng Q; Wang S; Fan J; Chen R; Gan W; Chen B; Pan CQ
Aliment Pharmacol Ther; 2020 Oct; 52(8):1377-1386. PubMed ID: 32852100
[TBL] [Abstract][Full Text] [Related]
20. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]